Ilex Medical (ILX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ilex Medical (ILX) has a cash flow conversion efficiency ratio of 0.068x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA44.77 Million ≈ $120.02K USD) by net assets (ILA660.36 Million ≈ $1.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ILX equity financing ratio to measure how much of total assets are equity-financed.
Ilex Medical - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Ilex Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ILX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Ilex Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ilex Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HealWELL AI Inc.
TO:AIDX
|
0.041x |
|
Areeya Property Public Company Limited
BK:A
|
-0.302x |
|
Bms Birlesik Metal Sanayi ve Ticaret AS
IS:BMSTL
|
0.040x |
|
LONCOR GOLD INC.
F:LO5
|
N/A |
|
Braemar Hotel & Resorts Inc
NYSE:BHR
|
0.044x |
|
STLLR Gold Inc.
TO:STLR
|
-0.045x |
|
Surya Toto Indonesia Tbk
JK:TOTO
|
-0.028x |
|
Dawson Geophysical Company
NASDAQ:DWSN
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Ilex Medical (2008–2024)
The table below shows the annual cash flow conversion efficiency of Ilex Medical from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Ilex Medical.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA646.49 Million ≈ $1.73 Million |
ILA81.63 Million ≈ $218.85K |
0.126x | -2.12% |
| 2023-12-31 | ILA623.51 Million ≈ $1.67 Million |
ILA80.43 Million ≈ $215.64K |
0.129x | +13.41% |
| 2022-12-31 | ILA613.10 Million ≈ $1.64 Million |
ILA69.74 Million ≈ $186.97K |
0.114x | -75.81% |
| 2021-12-31 | ILA575.57 Million ≈ $1.54 Million |
ILA270.68 Million ≈ $725.67K |
0.470x | +14.35% |
| 2020-12-31 | ILA443.54 Million ≈ $1.19 Million |
ILA182.40 Million ≈ $489.02K |
0.411x | +56.71% |
| 2019-12-31 | ILA323.48 Million ≈ $867.23K |
ILA84.89 Million ≈ $227.58K |
0.262x | +31.43% |
| 2018-12-31 | ILA293.49 Million ≈ $786.83K |
ILA58.60 Million ≈ $157.11K |
0.200x | -30.04% |
| 2017-12-31 | ILA266.15 Million ≈ $713.53K |
ILA75.96 Million ≈ $203.65K |
0.285x | +446.57% |
| 2016-12-31 | ILA244.51 Million ≈ $655.52K |
ILA12.77 Million ≈ $34.23K |
0.052x | -73.88% |
| 2015-12-31 | ILA225.99 Million ≈ $605.87K |
ILA45.17 Million ≈ $121.11K |
0.200x | -48.76% |
| 2014-12-31 | ILA204.60 Million ≈ $548.53K |
ILA79.81 Million ≈ $213.98K |
0.390x | +275.55% |
| 2013-12-31 | ILA214.38 Million ≈ $574.74K |
ILA22.27 Million ≈ $59.70K |
0.104x | -50.83% |
| 2012-12-31 | ILA259.96 Million ≈ $696.93K |
ILA54.92 Million ≈ $147.23K |
0.211x | +17.88% |
| 2011-12-31 | ILA282.99 Million ≈ $758.68K |
ILA50.71 Million ≈ $135.96K |
0.179x | -44.23% |
| 2010-12-31 | ILA120.80 Million ≈ $323.87K |
ILA38.82 Million ≈ $104.08K |
0.321x | -17.86% |
| 2009-12-31 | ILA127.32 Million ≈ $341.33K |
ILA49.81 Million ≈ $133.54K |
0.391x | +47.29% |
| 2008-12-31 | ILA109.44 Million ≈ $293.42K |
ILA29.07 Million ≈ $77.94K |
0.266x | -- |
About Ilex Medical
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine micros… Read more